Potomac Photonics on the Front Lines of Coronavirus Personal Protective Equipment Manufacturing

Potomac Photonics on the Front Lines of Coronavirus Personal Protective Equipment Manufacturing

Necessity is truly the mother of invention and the war against the coronavirus has created a worldwide wave of innovation to fight the pandemic.  No need is greater than the protection of healthcare workers, front line support, emergency teams, firefighters, police, and caregivers. With Personal Protective Equipment [PPE] in short supply, Potomac jumped into the front lines.  While our main area of focus is micro-manufacturing, we have experience with larger scale production for packaging, fixtures and other related products.  Pulling in all our engineering ingenuity, our creative team re-purposed equipment and processes to create much needed, life-saving PPE.

Visors

Visors were delivered to Montefiore Medical Center in NYC

Face masks worn alone are not as good a barrier as a face mask worn under a protective visor that covers the entire face.  Using a variety of standard manufacturing processes from laser machining to precision assembly, we were able to have a design ready quickly and begin production.  In partnership with TECLens our first batch of 1,000 visors was donated to Montefiore Hospital in the Bronx, New York and another batch is destined for Sinai Hospital in Baltimore, Maryland.  We are now working on a streamlined version of the visor that would be more user-friendly for workers who are already wearing lots more protective gear.

Microfluidic Devices

Of course, microfluidic technology is at the forefront of testing for the highly contagious Coronavirus.  Time is of the essence with the Covid-19 disease that it causes for several reasons. An infected person is far more likely to spread the virus than with flu and to a larger number of people.  So when a diagnosis is made it is crucial that the infected person immediately be quarantined and treated at the first sign of symptoms.  Microfluidic devices are able to cut diagnostic times from days to hours or even minutes, making them especially useful tools in the Coronavirus pandemic.  We are excited to contribute to research in this area of urgent need via several groups pioneering new diagnostics.

Contributing to the health and well-being of humankind has always been a hallmark of Potomac’s work.  But President and CEO Mike Adelstein adds, “This is a once in a lifetime opportunity for manufacturing companies to pull together our expertise and resources in order to win the war against Coronavirus!”

Other Posts

Microfluidic Device to counter the Antimicrobial Resistance (AMR) crisis in healthcare.

March 2020, Astek Diagnostics LLC, won the Maryland Innovation Initiative (MII) Award to develop a microfluidic device to detect bacterial infections in blood and evaluate the antimicrobial susceptibility. Astek, in partnership with Potomac Photonics Inc., will be designing a state-of-the art microfluidic lab-on-chip sensor for rapid detection of microorganisms in bodily fluids (like, blood, urine,…

  • Potomac Photonics
  • July 13, 2020

Black Lives Matter: From Rhetoric to Action for US Companies

We are seeing so many emails and blog posts from companies that say: “We Stand With Black Lives Matter Protesters”.  But when all is said and done, how does a company move beyond rhetoric to action? Saying you support the Black Lives Matter movement is a far cry from hiring and training black people locally…

  • Mike Adelstein
  • June 19, 2020

Potomac adds Precision microfluidic control capabilities with state-of-the-art Flow EZ pumps.

Quality assurance is at the heart of everything we manufacture at Potomac.  It is our attention to product and process control that ensures every microfluidic device, consumer product, medical device and electronic component meets our customers’ rigid standards. Manufacturing Microfluidic technology in particular requires strong quality processes.  In order to fabricate high performing microfluidic devices…

  • Mike Adelstein
  • June 10, 2020